BridgeMD
New treatment option for Neuro-Degenerative Disease
Official title 3D Printers for Autonomy in the Care of Inpatients in Continuing and Rehabilitation Care
ClinicalTrials.gov ID: NCT07087574
What this study is testing
- What it's testing
- Patients hospitalized in Continuing and Rehabilitation Care Units (CRCU) are for the most part elderly people suffering from neurodegenerative diseases, requiring individual, personalized rehabilitation care. Some of these patients require ergotherapy to help them regain functional ability in everyday activities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient hospitalized in a Continuing Care and Rehabilitation department ;
- Patient suffering from a neurodegenerative disease (Mini Mental Test score \> 15);
- Age ≥ 18 years;
- Patient with a score ≥ 3 on the "Eating" criterion of the Katz scale (corresponding to the need for at least partial assistance with meals).
You likely can't join if
- Opposition of the patient or his relatives to participating in the research ;
- Patient unable to use hands to eat (amputation, paralysis, etc.);
- Patient under court protection;
- Pregnant, parturient or breast-feeding woman;
- Any other reason which, in the opinion of the investigator, could interfere with the evaluation of the study objectives.
The study team makes the final eligibility decision.
Where it's taking place
- Hyères, Var, France
- La Garde, Var, France
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hyères, Var, France; La Garde, Var, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.